Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute decompensated heart failure: best evidence and current practice.

R Mehta1, D Feldman

  • 1Unit of Cardiovascular Diseases, The Ohio State University, Columbus, OH, USA.

Minerva Cardioangiologica
|December 8, 2005
PubMed
Summary

Acute decompensated heart failure (ADHF) is a critical condition with high mortality. Current guidelines lack specific management strategies, and existing treatments have limitations, necessitating new therapeutic approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Design, implementation and evaluation of an educational approach for patients with PICC line and midline].

Annales pharmaceutiques francaises·2023
Same author

Consensus statement from 2<sup>nd</sup> International Conference on Controversies in Vitamin D.

Reviews in endocrine & metabolic disorders·2020
Same author

Oncologist use and perception of large panel next-generation tumor sequencing.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

The interpersonal theory of suicide and adolescent suicidal behavior.

Journal of affective disorders·2015
Same author

Report from a forum on US heart allocation policy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Heart failure (HF) is a major cardiovascular health issue in Europe and the US.
  • Acute decompensated HF (ADHF) presents a significant mortality risk, often exceeding that of neoplastic or infective diseases.
  • Despite increased healthcare efforts, HF incidence continues to rise.

Purpose of the Study:

  • To highlight the limitations in current ADHF management guidelines in the US and Europe.
  • To discuss the challenges and limitations of existing pharmacotherapies for ADHF.
  • To emphasize the need for evolving therapeutic options beyond current palliative care.

Main Methods:

  • Review of current guidelines and pharmacotherapies for ADHF.
  • Analysis of the limitations of existing treatments like diuretics and neurohormonal antagonists.

Related Experiment Videos

  • Discussion of the unmet needs in advanced ADHF patient care.

    • Main Results:

    • US guidelines inadequately address ADHF, focusing instead on chronic HF.
    • European guidelines for ADHF are largely based on expert opinion, lacking robust randomized data.
    • Current pharmacotherapies (diuretics, neurohormonal antagonists, vasodilators, inotropes) have significant limitations in achieving hemodynamic relief and improving long-term outcomes in ADHF.

    Conclusions:

    • There is a critical need for updated guidelines and evidence-based management strategies for ADHF.
    • Existing treatments for ADHF have drawbacks, with diuretics potentially being maladaptive long-term.
    • Advanced ADHF patients refractory to conventional therapy have limited options, underscoring the importance of developing novel treatments.